Skip to main content
. 2017 May 19;60(8):1390–1399. doi: 10.1007/s00125-017-4289-0

Fig. 6.

Fig. 6

 Insulin response to a graded glucose infusion in participants with type 2 diabetes before and after receiving 12 weeks of treatment with semaglutide (n = 37, dark blue) or placebo (n = 38, light blue), and in healthy participants (n = 12, green). Dotted lines represent baseline values and solid lines represent end of treatment values